Stock-based compensation - Schedule of Share-Based Payment Award, Restricted Stock, Valuation Assumptions (Details) - USD ($) $ in Thousands	12 Months Ended			22 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Cumulative stock compensation expense related to PSA as of December 31, 2025	$ 21,271	$ 15,283	$ 19,903
Performance-based Restricted Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Fair value of PSA as of grant date	1,900
Q4 2024 change in estimated achievement probability	800
Q1 2025 modification	1,600
Cumulative stock compensation expense related to PSA as of December 31, 2025	3,100	$ 1,200		$ (4,300)
Remaining unrecognized non-cash compensation costs related to PSA	$ 0